Sitemap > Breaking Research > Metabolic & Hormonal Disorders
Displaying 1501 - 1550 of 3753 results
- Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension.
- Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats.
- Depression induces bone loss through stimulation of the sympathetic nervous system.
- Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease.
- FG 7142 specifically reduces meal size and the rate and regularity of sustained feeding in female rats: evidence that benzodiazepine inverse agonists reduce food palatability.
- Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators.
- Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.
- Abnormal function of C-fibers in patients with diabetic neuropathy.
- Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.
- Skp2 controls adipocyte proliferation during the development of obesity.
- Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach.
- Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
- Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
- Induction of cardiac uncoupling protein-2 expression and adenosine 5'-monophosphate-activated protein kinase phosphorylation during early states of diet-induced obesity in mice.
- 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease.
- Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.
- Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression.
- The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.
- The effect of moxonidine on endothelial dysfunction in metabolic syndrome.
- A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors.
- A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice.
- Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis.
- Down-regulation of PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: Attenuation of lipid accumulation and reduction of apoptosis.
- GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.
- Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
- The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes.
- Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
- Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
- Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes.
- The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.
- Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats.
- Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
- Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.
- Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors.
- The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation.
- Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
- Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
- Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes.
- Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
- Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.
- Effect of a statin on an in vitro model of endometriosis.
- Acceleration of atherosclerosis during the course of rheumatoid arthritis.
- Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.
- Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
- SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents.
- Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.
- Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
- Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts.
- Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
- Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 Next >